7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Landos Biopharma, Inc
(NASDAQ:LABP) 

LABP stock logo

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate in development is BT-11, an oral lanthionine synthetase C-like protein 2 (LANCL2) agonist for the treatment of ulcerative col...

Founded: 2017
CEO: Josep Bassaganya-Riera  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Landos Biopharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.96-3.39-2.83-2.26-1.7-1.13-0.570
Landos Biopharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.96-3.39-2.83-2.26-1.7-1.13-0.570
Landos Biopharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.032.063.094.125.156.187.21
Landos Biopharma P/S ratio ttm
202203 202204 202205 202206 202207 202208 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0400.47800.941,201.411,601.882,002.352,402.822,803.29
Landos Biopharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -9.46-8.1-6.75-5.4-4.05-2.7-1.350
Landos Biopharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.831.652.483.34.134.955.78
No extra charts and metrics for this ticker.